Dr. Maria G. Chong-Ramasute, MD

1. Office and hospital visits29696%
2. Lab and pathology114%

Medicare services

307vs 57447% below

Part D claims

7,041vs 16742.2 times

Medians across 689 internists in Iowa with Dmand AI profiles that report each measure.

1. 99214Office visit, established patient19965%: Services 199, Patients 111, Where In an office
2. 99213Office visit, established patient4113%: Services 41, Patients 32, Where In an office
3. 99308Nursing facility care289%: Services 28, Patients 16, Where In a facility
4. 99203Office visit, new patient155%: Services 15, Patients 15, Where In an office
5. 99309Nursing facility care134%: Services 13, Patients 11, Where In a facility

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

1. Pantoprazole Sodium3435%: Claims 343, Drug cost $24,118
2. Rosuvastatin Calcium3335%: Claims 333, Drug cost $30,370
3. Levothyroxine Sodium2704%: Claims 270, Drug cost $3,546
4. Gabapentin2664%: Claims 266, Drug cost $10,069
5. Metoprolol Succinate2093%: Claims 209, Drug cost $3,908

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

• Opioids2%188 of 7,810 claims
• Antibiotics2%144 of 7,810 claims
• Antipsychotics, patients 65 and over2%186 of 7,810 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Claims for drugs CMS names

2023: 8,8692024: 7,04121%

Drugs named by CMS: 150 in 2024, 172 in 2023.

1. Janssen Pharmaceuticals, Inc$16723%: General payments $167, Payments 12, Years 2016
2. Sanofi and Genzyme US Companies$16223%: General payments $162, Payments 12, Years 2016
3. AstraZeneca Pharmaceuticals LP$15522%: General payments $155, Payments 9, Years 2016
4. Sunovion Pharmaceuticals Inc.$7010%: General payments $70, Payments 5, Years 2016 to 2018
5. Pfizer Inc.$365%: General payments $36, Payments 3, Years 2016

Share is of all general payments to this clinician.